Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2008
02/12/2008CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
02/12/2008CA2220140C (2-morpholinylmethyl)benzamide derivatives
02/12/2008CA2219736C Device for transdermal electrotransport delivery of fentanyl and sufentanil
02/12/2008CA2208672C Immunotherapeutic imides/amides and their use for reducing levels of tnf.alpha.
02/12/2008CA2208206C Composition for treating tumors comprising lactose and a saccharide conjugate of a cytotoxic phenolic compound
02/12/2008CA2202137C Composition, device and method for enhanced electrotransport agent delivery
02/12/2008CA2174236C Superoxide dismutase and mimetics thereof
02/12/2008CA2172778C Cgrp antagonist used for the treatment of lichen and pruritus; composition thus produced
02/12/2008CA2131153C Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160
02/12/2008CA2104699C Sustained release drug delivery devices
02/07/2008WO2008017081A1 Compositions and methods for the modulation of jnk proteins
02/07/2008WO2008017029A2 Drug carriers, their synthesis, and methods of use thereof
02/07/2008WO2008017025A2 Combination therapy
02/07/2008WO2008017024A2 Method of treating chronic myelogenous leukemia cells
02/07/2008WO2008017000A2 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy
02/07/2008WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy
02/07/2008WO2008016968A2 Non-flushing niacin analogues, and methods of use thereof
02/07/2008WO2008016913A1 Biologically potent analogues of the dmt-tic pharmacophore and methods of use
02/07/2008WO2008016911A2 Replicating melatonin signaling in a fetus, newborn or suckling infant
02/07/2008WO2008016893A1 Smac peptidomimetics useful as iap inhibitors
02/07/2008WO2008016890A1 Antitumorigenic drug combination
02/07/2008WO2008016884A2 Soluble epoxide hydrolase inhibitors
02/07/2008WO2008016883A2 Inhibitors of plasma kallikrein
02/07/2008WO2008016842A1 Topical skin compositions, their preparation, and their use
02/07/2008WO2008016793A2 Methods, compositions and articles of manufacture for contributing to the treatment of cancers
02/07/2008WO2008016768A1 Phytoestrogenic formulations and uses thereof
02/07/2008WO2008016738A2 Antibacterial agents and related screening methods using small molecule macroarrays
02/07/2008WO2008016730A2 Compositions and methods for reducing cellular fat
02/07/2008WO2008016711A2 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
02/07/2008WO2008016708A2 Methods for treatment of radiation enteritis
02/07/2008WO2008016704A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof
02/07/2008WO2008016702A2 Combined use of (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1(2-thiazolyl)-1,8-naphthyridine-3-carboxylic
02/07/2008WO2008016700A2 N-oxide compounds for therapeutics uses
02/07/2008WO2008016692A2 Chemical compounds
02/07/2008WO2008016682A2 Aryl vinyl sulfides, sulfones, sulfoxides and sulfonamides, derivatives thereof and therapeutic uses thereof
02/07/2008WO2008016677A2 Preparation and utility of deuterated amphetamines
02/07/2008WO2008016675A1 P38 kinase inhibitors
02/07/2008WO2008016674A1 Agonists of the sphingosine- 1- phosphate receptor (slp)
02/07/2008WO2008016666A2 Certain chemical entities, compositions, and methods
02/07/2008WO2008016665A2 Imidazoacridine compounds for treating flt3 -mediated disorders
02/07/2008WO2008016661A2 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
02/07/2008WO2008016660A2 Imidazoacridine compounds for treating leukemias
02/07/2008WO2008016659A2 Agents for treating neurodegenerative diseases
02/07/2008WO2008016640A2 Use of poloxamer for the prevention and/or treatment of heart failure
02/07/2008WO2008016633A2 Combination therapy
02/07/2008WO2008016596A2 Pseudobase benzo [c] phenanthridines with improved efficacy, stability, and safety
02/07/2008WO2008016593A2 Bioactive depside and anthocyanin compounds, compositions, and methods of use
02/07/2008WO2008016547A2 Aurora kinase inhibitors from an encoded small molecule library
02/07/2008WO2008016534A1 Urotensin ii receptor antagonists
02/07/2008WO2008016340A1 Novel spiro-quinuclidinyl derivatives for the treatment of central nervous system disorders
02/07/2008WO2008016306A1 Non-allergenic ingredients and food products
02/07/2008WO2008016288A1 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof
02/07/2008WO2008016260A1 A pharmaceutical composition for oral comprising fenofibrate and preparation method thereof
02/07/2008WO2008016187A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound
02/07/2008WO2008016175A1 Activator for peroxisome proliferator activated receptor
02/07/2008WO2008016172A1 Metastasis inhibitor
02/07/2008WO2008016171A1 Prophylactic/therapeutic agent for renal dysfunction
02/07/2008WO2008016139A1 Fluorescent oleamide derivative and use thereof
02/07/2008WO2008016132A1 Benzyl phenyl glucopyranoside derivative
02/07/2008WO2008016131A1 Fused heterocyclic compound
02/07/2008WO2008016118A1 Agent targeting dopamine receptor and screening method therefor
02/07/2008WO2008016108A1 Agent for preventing infection
02/07/2008WO2008016107A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
02/07/2008WO2008016105A1 Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as active ingredient
02/07/2008WO2008016095A1 PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
02/07/2008WO2008016077A1 Adhesive preparation
02/07/2008WO2008016016A1 Aqueous liquid preparation containing amide compound
02/07/2008WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR
02/07/2008WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof
02/07/2008WO2008016002A1 AMYLOID β PRODUCTION REGULATOR CONTAINING PROTON PUMP INHIBITOR
02/07/2008WO2008015959A1 Pharmaceutical composition improved in absorption of pharmacologically active substance
02/07/2008WO2008015950A1 Acat inhibitor
02/07/2008WO2008015942A1 Therapeutic agent for neuroblastoma, method for screening for the therapeutic agent, and method for determination of prognosis of neuroblastoma
02/07/2008WO2008015794A1 Boronated quinazoline derivative
02/07/2008WO2008015763A1 Drug formulation containing fibrate medicament and process for producing the same
02/07/2008WO2008015695A2 Inclusion complex of olopatadine and cyclodextrin
02/07/2008WO2008015686A1 Stable multiparticulate formulations of didanosine
02/07/2008WO2008015680A2 Polycyclic dianthraquinones as inhibitors of inflammatory cytokines
02/07/2008WO2008015577A2 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
02/07/2008WO2008015563A2 Salts of rosuvastatin and processes for their preparation
02/07/2008WO2008015538A2 Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine
02/07/2008WO2008015530A2 Stable solid oral formulation of pantoprazole
02/07/2008WO2008015517A2 Ep2 agonists
02/07/2008WO2008015516A1 Fused tricyclic heterocycles for the treatment of schizophrenia
02/07/2008WO2008015453A1 Antimicrobials
02/07/2008WO2008015437A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
02/07/2008WO2008015429A2 Pharmaceutical compounds
02/07/2008WO2008015423A1 Quinoline and quinoxaline n-oxides as chk-1 inhibitors
02/07/2008WO2008015416A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
02/07/2008WO2008015403A1 Induction of analgesia in neuropathic pain
02/07/2008WO2008015374A2 Protein free formula
02/07/2008WO2008015340A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof
02/07/2008WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
02/07/2008WO2008015315A1 Thiourea-containing medicinal compounds for treating cancer in association with chemotheraputic agents or ionizing or non-ionizing radiation
02/07/2008WO2008015271A1 Pyrazolopyrimidines, a process for their preparation and the use as a medicine
02/07/2008WO2008015270A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
02/07/2008WO2008015269A1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
02/07/2008WO2008015266A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
02/07/2008WO2008015265A1 Anthracen derivatives and their use for the treatment of benign and malignant tumorous diseases
02/07/2008WO2008015253A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
1 ... 3387 3388 3389 3390 3391 3392 3393 3394 3395 3396 3397 3398 3399 3400 3401 3402 3403 3404 3405 3406 3407 ... 7860